SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-18-000239
Filing Date
2018-01-23
Accepted
2018-01-23 16:52:11
Documents
2
Effectiveness Date
2018-01-23

Document Format Files

Seq Description Document Type Size
1 dfan14a09271023_01232018.htm DFAN14A 11834
2 EX. 1 - INVESTOR PRESENTATION ex1todfan14a09271023_012318.pdf DFAN14A 1666242
  Complete submission text file 0000921895-18-000239.txt   2307846
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DFAN14A | Act: 34 | File No.: 001-35285 | Film No.: 18542938
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 13100 GREGG STREET SUITE A POWAY CA 92064
Business Address 1048 INDUSTRIAL COURT SUWANEE GA 30024 (858) 726-1600
DIGIRAD CORP (Filed by) CIK: 0000707388 (see all company filings)

IRS No.: 330145723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A
SIC: 3845 Electromedical & Electrotherapeutic Apparatus